[{"Assets_0_Q1_USD":56537000.0,"CommonStockSharesOutstanding_0_Q1_shares":7141189.0,"NetCashProvidedByUsedInOperatingActivities_1_Q1_USD":-10590000.0,"NetIncomeLoss_1_Q1_USD":2314000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q1_shares":5299751.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q1_shares":3656360.0,"StockholdersEquity_0_Q1_USD":31106000.0,"EarningsPerShareBasic_1_Q1_USD":0.54,"EarningsPerShareDiluted_1_Q1_USD":0.49,"Ticker":"VXRT","CIK":"72444","name":"VAXART, INC.","OfficialName":"Vaxart Inc Common Stock","form":"10-Q","period":"20180331","fy":"2018.0","fp":"Q1","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"564888665.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Biological Products (No Diagnostic Substances)","Market":"NASDAQ","SP500":"nan","filed":"20180515"}]